Skip to main content
SpringerLink
Log in
Book cover

Brackenridge’s Medical Selection of Life Risks pp 611–654Cite as

Palgrave Macmillan

Diseases of the Kidneys and Urinary Tract

  • Chapter

  • 67 Accesses

Abstract

The kidneys are important organs and are intimately related functionally to the cardiovascular system. Diseases of the kidneys and their outflow tracts are therefore of special importance in life underwriting. In addition to primary renal diseases, the kidneys may be secondarily involved by systemic disease processes, may be congenitally deformed or may become diseased by lesions affecting their respective outflow tracts.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   279.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Medical Impairment Study 1983. Boston: Society of Actuaries and Association of Life Insurance Medical Directors of America, 1986.

    Google Scholar 

  2. Abuelo JG. Proteinuria: diagnostic principles and procedures. Ann Intern Med 1983; 98: 86–191.

    Article  Google Scholar 

  3. Brenner BM, Coe FL, Rector MD (eds). Clinical Nephrology. Philadelphia: WB Saunders Company, 1987.

    Google Scholar 

  4. Travis LB, Brouhard BH, Kalia A. An Approach to the Child with Hematuria and Proteinuria. Norwalk, CT: Appleton-Century-Crofts, 1985.

    Google Scholar 

  5. Robinson RR. Isolated proteinuria in asymptomatic patients. Kidney Int 1980; 18: 395–406.

    Article  CAS  PubMed  Google Scholar 

  6. Robinson RR et al. Fixed and reproducible orthostatic proteinuria: light microscopic studies of the kidney. Am J Pathol 1961; 39: 291–306.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Rytand DA, Spreiter S. Prognosis in postural proteinuria. N Engl J Med 1981; 305: 618–21.

    Article  CAS  PubMed  Google Scholar 

  8. King SE. Postural adjustments and protein excretion by the kidney in renal diseases. Ann Intern Med 1957; 46: 360–77.

    Article  CAS  PubMed  Google Scholar 

  9. Shaw A, Risdon P, Lewis-Jackson J. Protein creatinine index and albustix in assessment of proteinuria. BMJ 1983; 287: 929–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Koopman MG et al. Circadian rhythm of proteinuria: consequences of the use of urinary protein: creatinine ratios. Nephrol Dial Transplant 1989; 4: 9–14.

    CAS  PubMed  Google Scholar 

  11. Ginsberg JM et al. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983; 309: 1543–6.

    Article  CAS  PubMed  Google Scholar 

  12. Schwab SJ et al. Quantitation of proteinuria by the use of protein to creatinine ratios in single urine samples. Arch Intern Med 1987; 147: 943–4.

    Article  CAS  PubMed  Google Scholar 

  13. Kristal B et al. Estimation of quantitative proteinuria by using the protein to creatinine ratio in random urine samples. Am J Nephrol 1988; 8: 198–203.

    Article  CAS  PubMed  Google Scholar 

  14. Minuk H. Understanding glomerular disease. On the Risk 1985; 3: 9–13.

    Google Scholar 

  15. Minuk H, Weir R. Understanding proteinuria and the protein/creatinine ratios. On the Risk 1991; 8: 18–27.

    Google Scholar 

  16. Barratt TM, McLaine PN, Soothill JF. Albumin excretion as a measure of glomerular dysfunction in children. Arch Dis Child 1970; 45: 496–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Nelson RG et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitis. N Engl J Med 1996; 335: 1636–42.

    Article  CAS  PubMed  Google Scholar 

  18. Parving H. Initiation and progression of diabetic nephropathy. N Engl J Med 1996; 335: 1682–3.

    Article  CAS  PubMed  Google Scholar 

  19. Houlihan C et al. Albumin to creatinine ratio: a screening test with limitations. American Journal of Kidney Diseases 2002; 39: 1183–9

    Article  CAS  PubMed  Google Scholar 

  20. Personal Communication. Dr. Robert Stout. Clinical Reference Laboratory.

    Google Scholar 

  21. Clark CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332: 1210–17.

    Article  PubMed  Google Scholar 

  22. Gerstein H et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421–6 19B.

    Article  CAS  PubMed  Google Scholar 

  23. Coresh J et al. prevalence of chronic kidney disease and decreased kidney function in the adult us population: third national health and nutrition examination survey. Am J Kidney Dis 2003; 41:1–12.

    Article  PubMed  Google Scholar 

  24. National Institutes of Health. Third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH Publication 01–3670. Bethesda, MD: National Institutes of Health; 2001.

    Google Scholar 

  25. Cameron J et al. The metabolic syndrome: prevalence worldwide populations. Endocrinol Metab Clin N Am 2004; 33: 351–75.

    Article  Google Scholar 

  26. Chen J et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167–74.

    Article  PubMed  Google Scholar 

  27. Yoshikawa N. Benign familial hematuria. Arch Pathol Lab Med 1988; 112: 794–7.

    CAS  PubMed  Google Scholar 

  28. Bailey RR. Familial hematuria due to thin basement membrane nephropathy. N Z Med J 1990; 103; 312–13.

    CAS  PubMed  Google Scholar 

  29. Sessa A, Meroni M, Battin G (eds). Hereditary nephritis. Contrib Nephrol 1990; 80: 95–100.

    Google Scholar 

  30. Munter P et al. Renal Insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am soc Nephrol 2002; 13: 745–53.

    Google Scholar 

  31. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929–37.

    Google Scholar 

  32. Shrier RW, Gottschalk CW (eds.). Diseases of the Kidney. Boston/Toronto: Little, Brown and Co, 1988.

    Google Scholar 

  33. International Study of Kidney Disease in Children. Minimal change nephrotic syndrome in children. Pediatrics 1984; 173: 497.

    Google Scholar 

  34. Cameron JS. The long term outcome of glomerular diseases. In: Schrier RW, Gottschalk CW (eds). Diseases of the Kidney. Boston/Toronto: Little, Brown and Co, 1988; 2127–89.

    Google Scholar 

  35. Honkanen E. Survival in idiopathic membranous-glomerulonephritis. Clin Nephrol 1986; 25: 122–8.

    CAS  PubMed  Google Scholar 

  36. Madaio MP, Harrington JT. The diagnosis of acute glomerulonephritis. N Engl J Med 1983; 1299–1302.

    Article  Google Scholar 

  37. Potter EV et al. Twelve to seventeen year follow-up of patients with post streptococcal acute glomerulonephritis in Trinidad. N Engl J Med 1982; 307: 725–9.

    Article  CAS  PubMed  Google Scholar 

  38. Baldwin DS. Post streptococcal glomerulonephritis: a progressive disease. Am J Med 1977; 62: 1–11.

    Article  CAS  PubMed  Google Scholar 

  39. Schena F. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990;89: 209–15.

    Article  ADS  CAS  PubMed  Google Scholar 

  40. Alamartine E et al. Prognostic factors in mesangial IgA glomerulonephritis. An extensive study with univariate and multivariate analysis. Am J Kidney Dis 1991; 18: 12–19.

    Article  CAS  PubMed  Google Scholar 

  41. Kitajima T, Murakami M, Sakai O. Clinical pathological features in the Japanese patients with IgA nephropathy. Jpn J Med 1983; 22: 219.

    Article  CAS  PubMed  Google Scholar 

  42. Beukhof J et al. Toward individual prognosis of IgA nephropathy. Kidney Int 1986; 29: 549–56.

    Article  CAS  PubMed  Google Scholar 

  43. Heilman RL, Offord MS, Holley KE. Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis 1987; 9: 98–107.

    Article  CAS  PubMed  Google Scholar 

  44. Cameron JS et al. Idiopathic mesangiocapillary glomerulonephritis. Am J Med 1983; 74: 175–92.

    Article  CAS  PubMed  Google Scholar 

  45. Schmitt H et al. Long term prognosis of membra-noproliferative glomerulonephritis type 1. Nephron 1990; 55: 242–50.

    Article  CAS  PubMed  Google Scholar 

  46. McEnery PT. Membranoproliferative glomerulonephritis. The Cincinnati experience: cumulative renal survival from 1957 to 1989. J Pediatr 1990; 116:S109–14.

    Article  CAS  PubMed  Google Scholar 

  47. Suina J et al. Mortality rates among patients with end-stage renal disease in Canada 1981–1986. Can Med Assoc J 1989; 141: 667–82.

    Google Scholar 

  48. Luke R. Nephrosclerosis. In: Schrier RW, Gottschalk CW (eds). Diseases of the Kidney. Boston/Toronto: Little, Brown and Co, 1988; 1573–95.

    Google Scholar 

  49. Toto R et al. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med 1991; 115: 513–19.

    Article  CAS  PubMed  Google Scholar 

  50. Keane WF et al. Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Intern Med 1989; 111: 503–16.

    Article  CAS  PubMed  Google Scholar 

  51. Rostand S et al. Renal insufficiency in treated essential hypertension. N Engl J Med 1989; 320: 684–8.

    Article  CAS  PubMed  Google Scholar 

  52. Grün J, Klienknecht D, Droz D. Acute interstitial nephritis. In: Schrier RW, Gottschalk CW (eds). Diseases of the Kidney. Boston/Toronto: Little, Brown and Co, 1988; 1461–87.

    Google Scholar 

  53. Lipsky B. Urinary tract infections in men. Ann Intern Med 1989; 110: 138–50.

    Article  CAS  PubMed  Google Scholar 

  54. Eknoyan G. Chronic tubulointerstitial nephropathies. In: Schrier RW, Gottschalk CW (eds). Diseases of the Kidney. Boston/Toronto: Little, Brown and Co, 1988; 2197–221.

    Google Scholar 

  55. Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse analgesics containing phenacetin. N Engl J Med 1983; 308: 357–62.

    Article  CAS  PubMed  Google Scholar 

  56. Bosniak M. The current radiological approach to renal cysts. Radiology 1986; 158: 1–10.

    Article  CAS  PubMed  Google Scholar 

  57. Madewell J, Hartman D, Lichtenstein J. Radiologic-pathologic correlations in cystic disease of the kidney. Radiol Clin N Am 1979; 17: 261–79.

    CAS  PubMed  Google Scholar 

  58. Kimberling WJ et al. Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 913–18.

    Article  CAS  PubMed  Google Scholar 

  59. Leier CV et al. Cardiovascular abnormalities associated with adult polycystic kidney diseases. Ann Intern Med 1984; 100: 683–8.

    Article  CAS  PubMed  Google Scholar 

  60. Godela M. Fick-Brosnahangm GM. Polycystic and Acquired Cystic Kidney Disease in Primer on Kidney Diseases 3rd edn. National Kidney Foundation, Arthur Greenberg (ed). 2001; 303–13.

    Google Scholar 

  61. Florijn KW et al. A century of mortality in five large families with polycystic kidney disease. Am J Kidney Dis 1995; 25: 370–4.

    Article  CAS  PubMed  Google Scholar 

  62. Levey AS, Pauker SG, Kassirer JP. Occult intracranial aneurisms in polycystic kidney disease. N Engl J Med 1983; 308: 986–94.

    Article  CAS  PubMed  Google Scholar 

  63. Demetriou K et al. Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations. Nephrol Dial Transplant. 2000; 15(2): 205–11.

    Article  CAS  PubMed  Google Scholar 

  64. Cottram RS, Kumur V, Robbins SL. Robbins Pathologic Basis of Disease, 4th edn. Philadelphia: WB Saunders Co, 1989.

    Google Scholar 

  65. Maffly RH. Nephrolithiasis. In: Rubenstein, Federman (eds). Scientific Am Med 1986; 8: 1–10.

    Google Scholar 

  66. 1951 Impairment Study. New York: Society of Actuaries, 1954.

    Google Scholar 

  67. Smith JM, O’Flynn JD. Vesical Stone: the clinical features of 652 cases. J Irish Med Assoc 1975; 68: 85.

    CAS  Google Scholar 

  68. Jardin A et al. Alfuzosin for treatment of benign prostatic hypertrophy. Lancet 1991; 337: 1457–61.

    Article  CAS  PubMed  Google Scholar 

  69. Gittes R. Carcinoma of the prostate. N Engl J Med 1991; 324: 236–45.

    Article  CAS  PubMed  Google Scholar 

  70. Catalona WJ et al. Evaluation of percentage of free serum prostate-specific-antigen to improve specificity of prostate cancer screening. JAMA 1995; 274: 1214–20.

    Article  CAS  PubMed  Google Scholar 

  71. Tolkoff-Rubin N. Dialysis and transplantation. Scientific Am Med 1991; 11: 1–25.

    Google Scholar 

  72. Greca GL et al. Updating on continuous ambulatory peritoneal dialysis. Contrib Nephrol 1990; 84: 1–9.

    Article  PubMed  Google Scholar 

  73. Rosansky SJ, Eggers PW. Trends in the US end stage renal disease population 1973–1983. Am J Kidney Dis 1987; 9: 91–7.

    Article  CAS  PubMed  Google Scholar 

  74. Kakaver H et al. The recent US experience in the treatment of end stage renal disease by dialysis and transplantation. N Engl J Med 1983; 308: 1558–63.

    Article  Google Scholar 

  75. McCracker B. In: Lew EA, Gajewski J (eds). Medical Risks: trends in mortality by age and time elapsed. Association of Life Insurance Medical Directors of America, 1990.

    Google Scholar 

  76. Vollmer WM, Wahl P, Blagg CR. Survival with dialysis and transplantation in patients with end stage renal disease. N Engl J Med 1983; 304: 1553–8.

    Article  Google Scholar 

  77. Opelz G et al. for the Collaborative Transplant Study. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet 1991; 338: 461–463.

    Article  CAS  PubMed  Google Scholar 

  78. Doxiadis IN et al. Association between specific HLA combinations and probability of allograft loss: the taboo concept. Lancet 1996; 348: 850–3.

    Article  CAS  PubMed  Google Scholar 

  79. Terasaki PI et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333–6.

    Article  CAS  PubMed  Google Scholar 

  80. Cardella C. Kidney transplantation: how has the long-term outlook improved? CLIMOA Proceedings 1996; 182–9.

    Google Scholar 

  81. Wheeler DC. Cardiovascular disease in patients with chronic renal failure. Lancet 1996; 348: 1673–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Howard L Minuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Swiss Re Life & Health, London, UK

    R. D. C. Brackenridge MD FRCP (Glasg) (Consulting Medical Officer) & Richard S. Croxson MB FRACP (Cardiologist, Chief Medical Officer) (Consulting Medical Officer) &  (Cardiologist, Chief Medical Officer)

  2. Toronto General Hospital, Toronto, Ontario, Canada

    Ross MacKenzie MD, FRCP (C) FACC (Cardiologist) (Cardiologist)

Copyright information

© 2006 Palgrave Macmillan, a division of Macmillan Publishers Limited

About this chapter

Cite this chapter

Minuk, H.L. (2006). Diseases of the Kidneys and Urinary Tract. In: Brackenridge, R.D.C., Croxson, R.S., MacKenzie, R. (eds) Brackenridge’s Medical Selection of Life Risks. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-56632-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-56632-7_24

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-1-349-56634-1

  • Online ISBN: 978-1-349-56632-7

  • eBook Packages: Palgrave History CollectionHistory (R0)

Publish with us

Policies and ethics

Search

Navigation